ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT00132379 · COMPLETED

Trial details

NCT number: NCT00132379
Sponsor: Active Biotech AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2005-11-01
Primary completion: 2006-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.